Quinact

• Antimalarials
• Antiarrhythmic Agents
• Antiarrhythmic Agents
• ATC:C01BA01

• Apo-Quinidine
• Biquin Durules
• Cardioquin
• Chinidin
• Cin-Quin
• Coccinine
• Conchinin
• Conchinine
• Conquinine
• Duraquin
• Kinidin
• Novoquinidin
• Pitayin
• Pitayine
• Quin-Release
• Quinact
• Quinaglute
• Quinaglute Dura-Tabs
• Quinalan
• Quinate
• Quinatime
• Quindine
• Quinicardine
• Quinidex
• Quinidex Extentabs
• Quinidine Gluconate
• Quinidine Sulfate
• Quinine, Polymers
• Quinora

No information avaliable

C₂₀H₂₄N₂O₂

http://www.rxlist.com/cgi/generic/quinidine.htm

Quinact FDA

Aucune information disponible

324.417 g/mol

174 ^oC

140 mg / L

Solid

2.534

Solution

Pour le traitement de pré-excitation ventriculaire et des arythmies cardiaques

Quinidine, un anticonvulsivant hydantoïne, est utilisé seul ou avec des anticonvulsivants phénobarbital ou d'autres pour gérer les crises tonico-cloniques, convulsions psychomotrices, syndromes de douleur neuropathique diabétique, y compris les neuropathie, induites par les digitaliques arythmies cardiaques, et les arythmies cardiaques associées à intervalle QT prolongation.

Aucune information disponible

Aucune information disponible

Before prescribing QUINAGLUTE® as prophylaxis against recurrence of atrial fibrillation, the physician should inform the patient of the risks and benefits to be expected. Discussion should include the facts

• that the goal of therapy will be a reduction (probably not to zero) in the frequency of episodes of atrial fibrillation; and
• that reduced frequency of fibrillatory episodes may be expected, if achieved, to bring symptomatic benefit; but
• that no data are available to show that reduced frequency of fibrillatory episodes will reduce the risks of irreversible harm through stroke or death; and in fact
• that such data as are available suggest that treatment with QUINAGLUTE® is likely to increase the patient's risk of death.

To confirm whether this is the most current prescribing information available on Quinaglute®, or to obtain the most current prescribing information, please call Berlex Laboratories at 1-888-BERLEX-4 (choose option #4, Product Usage Information).

Les humains et autres mammifères